EGFR and central nervous system cancer: Consistent with this, Zhu and colleagues showed that simultaneous activation of wild-type and/or mutant EGFR, combined with the deletion of Ink4A/Arf and PTEN tumor suppressor genes in the adult mouse brain, led to the rapid onset of highly aggressive gliomas that closely mimic the pathology of human glioblastoma.